A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
PHASE3
This study will evaluate the relative efficacy and safety of prasugrel and ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
NA
This is a multicenter, open-label, randomized controlled study meant to com...
Status
Unknown
Location
Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences
Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers
PHASE1
Study to establish the bioequivalence of a new formulation of Asasantin ER ...
To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.
NA
This study aims to evaluate the treatment of Chronic total occlusion (CTO) ...
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
NA
The management of patients with unprotected left main coronary artery (LMCA...